The aim of this study is to assess the circulating level of interleukin (IL)-6 and IL-18 in patients with ischemic and idiopathic DCM who suffer from heart failure symptoms in order to determine the effects of two main etiologies of DCM on expression of these two interleukins. This evidence concerns the gene IL6 and familial dilated cardiomyopathy.